Body Dysmorphic Disorders
Somatoform Disorders
Delusions
Rhinoplasty
Pimozide
Obsessive-Compulsive Disorder
Serotonin Uptake Inhibitors
Diagnostic and Statistical Manual of Mental Disorders
Fluvoxamine
Phobic Disorders
Psychiatric Status Rating Scales
Cognitive Therapy
Social Adjustment
Fluoxetine
Severity of Illness Index
Comorbidity
Development and validation of a male specific body checking questionnaire. (1/52)
(+info)Preliminary evidence that estradiol moderates genetic influences on disordered eating attitudes and behaviors during puberty. (2/52)
(+info)Understanding body image in African American and Caucasian first-graders: a partnership with the YMCA. (3/52)
(+info)Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. (4/52)
(+info)High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. (5/52)
(+info)A de novo complex chromosomal rearrangement involving chromosomes 2, 8 and 13 in a dysmorphic case with polysyndactyly. (6/52)
We report herein a case with dysmorphic features, polysyndactyly and psychomotor mental retardation, who had an apparently balanced de novo translocation between chromosomes 8 and 13 as well as a de novo insertion within chromosome 2 itself. This case is worth mentioning in the sense that it bears two de novo rearrangements with five breakpoints. The correlation between the possible disrupted genes within the given breakpoints and the phenotype of the case will be discussed. (+info)Inverted face processing in body dysmorphic disorder. (7/52)
(+info)Delusional disorder-somatic type (or body dysmorphic disorder) and schizophrenia: a case report. (8/52)
With regard to delusional disorder-somatic subtype there may be a relationship with body dysmorphic disorder. There are reports that some delusional disorders can evolve to become schizophrenia. Similarly, the treatment of such disorders with antipsychotics has been documented. This report describes a case of delusional disorder - somatic type - preceding a psychotic episode and its successful treatment with an antipsychotic drug, thus contributing to what has been documented on the subject. (+info)Body Dysmorphic Disorder (BDD) is a mental health condition where an individual becomes obsessed with perceived flaws or defects in their appearance, which are often either minimal or not observable to others. The preoccupation with these real or imagined physical imperfections can cause significant distress and impairment in social, occupational, and other areas of functioning.
Individuals with BDD may spend excessive time examining themselves in the mirror, seeking reassurance from others, or trying to camouflage or cover up their perceived flaws. They may also engage in repetitive behaviors such as skin picking, hair pulling, or excessive grooming. The obsessions and compulsions related to BDD can lead to significant anxiety, depression, and social isolation.
BDD typically begins in adolescence and is more common in women than men. It is important to note that BDD is different from normal concerns about appearance, as the preoccupation with perceived flaws in BDD is excessive and causes significant distress or impairment. Treatment for BDD often involves a combination of medication and cognitive-behavioral therapy (CBT).
Somatoform disorders are a group of psychological disorders characterized by the presence of physical symptoms that cannot be fully explained by a medical condition or substance abuse. These symptoms cause significant distress and impairment in social, occupational, or other important areas of functioning. The individual's belief about the symptoms is not consistent with the medical evaluation and often leads to excessive or repeated medical evaluations.
Examples of somatoform disorders include:
1. Somatization disorder: characterized by multiple physical symptoms that cannot be explained medically, affecting several parts of the body.
2. Conversion disorder: characterized by the presence of one or more neurological symptoms (such as blindness, paralysis, or difficulty swallowing) that cannot be explained medically and appear to have a psychological origin.
3. Pain disorder: characterized by chronic pain that is not fully explained by a medical condition.
4. Hypochondriasis: characterized by an excessive preoccupation with having a serious illness, despite reassurance from medical professionals.
5. Body dysmorphic disorder: characterized by the obsessive idea that some aspect of one's own body part or appearance is severely flawed and warrants exceptional measures to hide or fix it.
It's important to note that these disorders are not caused by intentional deceit or malingering, but rather reflect a genuine belief in the presence of physical symptoms and distress related to them.
A delusion is a fixed, false belief that is firmly held despite evidence to the contrary and is not shared by others who hold similar cultural or religious beliefs. Delusions are a key symptom of certain psychiatric disorders, such as schizophrenia and delusional disorder. They can also be seen in other medical conditions, such as dementia, brain injury, or substance abuse.
Delusions can take many forms, but some common types include:
* Persecutory delusions: the belief that one is being targeted or harmed by others
* Grandiose delusions: the belief that one has special powers, talents, or importance
* Erotomanic delusions: the belief that someone, often of higher social status, is in love with the individual
* Somatic delusions: the belief that one's body is abnormal or has been altered in some way
* Religious or spiritual delusions: the belief that one has a special relationship with a deity or religious figure
Delusions should not be confused with overvalued ideas, which are strongly held beliefs based on subjective interpretation of experiences or evidence. Overvalued ideas may be shared by others and can sometimes develop into delusions if they become fixed and firmly held despite contradictory evidence.
Body image is a person's perception and attitude towards their own physical appearance, shape, and size. It involves how a person thinks and feels about their body, including their self-perceived strengths and flaws. Body image can be influenced by many factors, such as cultural and societal standards of beauty, personal experiences, and media messages. A positive body image is associated with higher self-esteem, confidence, and overall well-being, while a negative body image can contribute to emotional distress, anxiety, depression, and disordered eating behaviors.
Rhinoplasty is a surgical procedure performed on the nose to reshape its structure or improve its function. This may involve altering the bone, cartilage, or soft tissues of the nose to change its appearance, straighten its bridge, reduce or increase its size, narrow its width at the nostrils, or change the angle between the nose and upper lip. It can also be done to correct birth defects, injuries, or help relieve breathing problems. The procedure is usually performed by an otolaryngologist (ear, nose, and throat specialist) or a plastic surgeon, and it requires a thorough understanding of nasal anatomy and function.
Pimozide is an antipsychotic medication that is primarily used to treat chronic tics and Tourette's disorder. It works by blocking the action of dopamine, a neurotransmitter in the brain that is involved in regulating movement and mood. By blocking dopamine receptors, pimozide helps to reduce the severity and frequency of tics and other symptoms associated with these conditions.
Pimozide may also be used off-label for the treatment of other conditions, such as severe behavioral problems in children with developmental disabilities. It is important to note that pimozide can have serious side effects, including cardiac arrhythmias and neurological symptoms, and should only be prescribed by a healthcare professional who is experienced in managing its use.
As with all medications, it's essential to follow the dosage instructions carefully and to report any unusual or concerning symptoms to your healthcare provider promptly.
Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by the presence of obsessions and compulsions. Obsessions are recurrent and persistent thoughts, urges, or images that are intrusive, unwanted, and often distressing. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to an obsession or according to rigid rules, and which are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation. These obsessions and/or compulsions cause significant distress, take up a lot of time (an hour or more a day), and interfere with the individual's daily life, including social activities, relationships, and work or school performance. OCD is considered a type of anxiety disorder and can also co-occur with other mental health conditions.
Serotonin uptake inhibitors (also known as Selective Serotonin Reuptake Inhibitors or SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. They work by increasing the levels of serotonin, a neurotransmitter in the brain that helps regulate mood, appetite, and sleep, among other functions.
SSRIs block the reuptake of serotonin into the presynaptic neuron, allowing more serotonin to be available in the synapse (the space between two neurons) for binding to postsynaptic receptors. This results in increased serotonergic neurotransmission and improved mood regulation.
Examples of SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications are generally well-tolerated, with side effects that may include nausea, headache, insomnia, sexual dysfunction, and increased anxiety or agitation. However, they can have serious interactions with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting an SSRI.
The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.
The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.
It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.
Fluvoxamine is a type of antidepressant known as a selective serotonin reuptake inhibitor (SSRI). It works by increasing the levels of serotonin, a neurotransmitter in the brain that helps maintain mental balance. Fluvoxamine is primarily used to treat obsessive-compulsive disorder (OCD) and may also be prescribed for other conditions such as depression, panic disorder, or social anxiety disorder.
The medical definition of Fluvoxamine can be stated as:
Fluvoxamine maleate, a selective serotonin reuptake inhibitor (SSRI), is a psychotropic medication used primarily in the treatment of obsessive-compulsive disorder (OCD). It functions by increasing the availability of serotonin in the synaptic cleft, which subsequently modulates neurotransmission and helps restore emotional balance. Fluvoxamine may also be employed off-label for managing other conditions, such as depression, panic disorder, or social anxiety disorder, subject to clinical judgment and patient needs.
A phobic disorder is a type of anxiety disorder characterized by an excessive and irrational fear or avoidance of specific objects, situations, or activities. This fear can cause significant distress and interfere with a person's daily life. Phobic disorders are typically classified into three main categories: specific phobias (such as fear of heights, spiders, or needles), social phobia (or social anxiety disorder), and agoraphobia (fear of open spaces or situations where escape might be difficult).
People with phobic disorders often recognize that their fear is excessive or unreasonable, but they are unable to control it. When exposed to the feared object or situation, they may experience symptoms such as rapid heartbeat, sweating, trembling, and difficulty breathing. These symptoms can be so distressing that individuals with phobic disorders go to great lengths to avoid the feared situation, which can have a significant impact on their quality of life.
Treatment for phobic disorders typically involves cognitive-behavioral therapy (CBT), which helps individuals identify and challenge their irrational thoughts and fears, as well as exposure therapy, which gradually exposes them to the feared object or situation in a safe and controlled environment. In some cases, medication may also be recommended to help manage symptoms of anxiety.
Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.
The purpose of using Psychiatric Status Rating Scales is to:
1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.
Examples of Psychiatric Status Rating Scales include:
1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.
It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.
Cognitive Therapy (CT) is a type of psychotherapeutic treatment that helps patients understand the thoughts and feelings that influence behaviors. It is a form of talk therapy where the therapist and the patient work together to identify and change negative or distorted thinking patterns and beliefs, with the goal of improving emotional response and behavior.
Cognitive Therapy is based on the idea that our thoughts, feelings, and behaviors are all interconnected, and that negative or inaccurate thoughts can contribute to problems like anxiety and depression. By identifying and challenging these thoughts, patients can learn to think more realistically and positively, which can lead to improvements in their mood and behavior.
In cognitive therapy sessions, the therapist will help the patient identify negative thought patterns and replace them with healthier, more accurate ways of thinking. The therapist may also assign homework or exercises for the patient to practice between sessions, such as keeping a thought record or challenging negative thoughts.
Cognitive Therapy has been shown to be effective in treating a wide range of mental health conditions, including depression, anxiety disorders, eating disorders, and post-traumatic stress disorder (PTSD). It is often used in combination with other forms of treatment, such as medication, and can be delivered individually or in group settings.
Social adjustment, in the context of mental health and psychology, refers to an individual's ability to adapt and function effectively within their social environment. It involves developing and maintaining positive relationships with others, fulfilling various social roles (such as being a family member, friend, or employee), and meeting the expectations and demands of one's social group.
Social adjustment can be affected by various factors, including an individual's personality traits, coping skills, mental and physical health status, and life experiences. Poor social adjustment can lead to feelings of isolation, loneliness, and dissatisfaction with life, as well as increased risk for mental health problems such as depression and anxiety.
Assessing social adjustment is an important aspect of mental health care, as it can provide valuable insights into an individual's overall functioning and quality of life. Treatments such as psychotherapy and social skills training may be used to help improve social adjustment in individuals who are struggling in this area.
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) medication that is primarily used to treat major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder. It works by increasing the levels of serotonin, a neurotransmitter in the brain that helps maintain mental balance.
Fluoxetine is available under the brand name Prozac and is also available as a generic medication. It comes in various forms, including capsules, tablets, delayed-release capsules, and liquid solution. The typical starting dose for adults with depression is 20 mg per day, but the dosage may be adjusted based on individual patient needs and response to treatment.
Fluoxetine has a relatively long half-life, which means it stays in the body for an extended period of time. This can be beneficial for patients who may have difficulty remembering to take their medication daily, as they may only need to take it once or twice a week. However, it also means that it may take several weeks for the full effects of the medication to become apparent.
As with any medication, fluoxetine can cause side effects, including nausea, dry mouth, sleepiness, insomnia, dizziness, and headache. In some cases, it may also increase the risk of suicidal thoughts or behavior in children, adolescents, and young adults, particularly during the initial stages of treatment. It is important for patients to discuss any concerns about side effects with their healthcare provider.
A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.
Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.
It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.
I am not a medical doctor, but I can provide you with some information on this topic. Self-concept is more commonly discussed in psychology than in medicine, but it still has relevance to understanding individual experiences and behaviors in health and illness.
Self-concept refers to an individual's perception, beliefs, and attitudes about themselves, encompassing various dimensions such as:
1. Physical self (how one perceives their physical appearance, abilities, and health)
2. Social self (how one perceives their relationships with others, social roles, and status)
3. Psychological or personal self (how one perceives their personality traits, values, and beliefs)
Self-concept can influence how people view their own health, cope with illness, and engage in health behaviors. For example, a positive self-concept may contribute to better adherence to treatment plans and healthier lifestyle choices, while negative self-concepts might lead to poorer health outcomes due to decreased motivation or self-efficacy.
Understanding an individual's self-concept can help healthcare professionals tailor their communication style, recommendations, and interventions to better meet the patient's needs and preferences.
Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.